LYEL:NASDAQ
Lyell Immunopharma Inc
8,12 USD
arrow_downward
-0,85%(-0,070) 1D
8,12 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 16-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LYEL...
Open
8,24 USD
High
8,44 USD
Low
7,92 USD
Mkt. cap
198,98 млн
Avg. vol.
158,44 миң
Volume
194,96 миң
52-wk high
45,00 USD
52-wk low
7,32 USD
EPS
-12,01 USD
Beta
-0,03
Shares outstanding
24,50 млн
No. of employees
161
Open
8,24 USD
High
8,44 USD
Low
7,92 USD
Mkt. cap
198,98 млн
Avg. vol.
158,44 миң
Volume
194,96 миң
52-wk high
45,00 USD
52-wk low
7,32 USD
EPS
-12,01 USD
Beta
-0,03
Shares outstanding
24,50 млн
No. of employees
161
News stories
From web sources and news partners
ad-hoc-news.de
·
55 мүнөт мурун
Eleven analysts target Ares Capital stock at USD 20.60
The Globe and Mail
·
1 саат мурун
Ethereum Dramatically Outperformed the S&P 500 in Q3. Is It Finally Time to Load Up on Ethereum?
Cryptonews.net
·
1 саат мурун
The S&P 500 Is Near Record Highs: But Most Stocks Are Already in a Bear Market
Yahoo Finance
·
8 саат мурун
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
About Lyell Immunopharma Inc
CEO-
Employees161
Founded2018
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
Sector-
Websitelyell.com